FDA advisory committee has recommended a booster dose of Moderna’s COVID-19 vaccine
BREAKING NEWS: FDA advisory committee has unanimously recommended a booster dose of Moderna’s COVID-19 vaccine for those aged 65 and older and at high risk due to underlying conditions or their jobs
- The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine
- Boosters shots will only be approved for those aged 65 and older at high risk due to their jobs
An advisory committee for the U.S. Food and Drug Administration (FDA) has voted to recommend approval of booster doses of Moderna’s COVID-19.
The boosters have only been approved for older adults aged 65 and older and those who are at high risk of developing a severe case of the virus due to underlying conditions.
It comes almost exactly one month after the Vaccines and Related Biological Products Advisory Committee (VRBPAC) approved boosters for the Pfizer-BioNTech vaccine
The FDA’s advisory committee has voted to recommend approval of Covid booster shots of Moderna’s vaccine. Pictured: A healthcare worker holds a vial of the Moderna COVID-19 vaccine in New York City, January 2021
In August, the White House that COVID-19 vaccine booster shots would be rolled out for all Americans starting September 20.
At the time, the Biden administration released studies citing waning immunity and the ability of the Delta variant to cause breakthrough infections.
However, officials at the FDA and Centers for Disease Control and Prevention (CDC) pushed back, saying there wasn’t enough evidence that the efficacy of the vaccines were declining.
This lead to boosters for Pfizer’s vaccine not being rolled out until September 22 – past the targeted roll out date – and only for specific groups, just like Moderma.
Next, Moderna’s booster shot will be need to be authorized by the FDA and approved by the Centers for Disease Control and Prevention’s (CDC) advisory committee.
This is a breaking news story and will be updated.